Ventricular tachycardia screening: Difference between revisions
Aditya Ganti (talk | contribs) No edit summary |
Aditya Ganti (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
== | According to the 2017 American Heart Association guidelines screening of first-degree relatives is recommended when a patient presents with any of the symptoms such as [[Long QT syndrome|QT syndrome]], [[Hypertrophic cardiomyopathy|hypertrophic]] or [[dilated cardiomyopathy]] and right ventricular dysplasia | ||
==Screening== | |||
According to the 2017 American Heart Association /American College of Cardiology/Heart Rhythm Society guideline screening of first-degree relatives is recommended when a patient is identified as having any of the following:<ref name="pmid5731530">{{cite journal |vauthors=Shoubkhova TS |title=[Determination of the particle size of suspensions of dried bacteria by the method of turbidimetric analysis] |language=Russian |journal=Zh. Mikrobiol. Epidemiol. Immunobiol. |volume=45 |issue=7 |pages=108–10 |date=July 1968 |pmid=5731530 |doi= |url=}}</ref><ref name="pmid30554599">{{cite journal |vauthors=Flannery MD, La Gerche A |title=Sudden Death and Ventricular Arrhythmias in Athletes: Screening, De-Training and the Role of Catheter Ablation |journal=Heart Lung Circ |volume=28 |issue=1 |pages=155–163 |date=January 2019 |pmid=30554599 |doi=10.1016/j.hlc.2018.10.004 |url=}}</ref> | According to the 2017 American Heart Association /American College of Cardiology/Heart Rhythm Society guideline screening of first-degree relatives is recommended when a patient is identified as having any of the following:<ref name="pmid5731530">{{cite journal |vauthors=Shoubkhova TS |title=[Determination of the particle size of suspensions of dried bacteria by the method of turbidimetric analysis] |language=Russian |journal=Zh. Mikrobiol. Epidemiol. Immunobiol. |volume=45 |issue=7 |pages=108–10 |date=July 1968 |pmid=5731530 |doi= |url=}}</ref><ref name="pmid30554599">{{cite journal |vauthors=Flannery MD, La Gerche A |title=Sudden Death and Ventricular Arrhythmias in Athletes: Screening, De-Training and the Role of Catheter Ablation |journal=Heart Lung Circ |volume=28 |issue=1 |pages=155–163 |date=January 2019 |pmid=30554599 |doi=10.1016/j.hlc.2018.10.004 |url=}}</ref> | ||
*Long QT syndrome | |||
*[[Long QT syndrome|QT syndrome]] | |||
*Hypertrophic or dilated cardiomyopathy | *[[Hypertrophic cardiomyopathy|Hypertrophic]] or [[dilated cardiomyopathy]] | ||
*Right ventricular dysplasia | *Right ventricular dysplasia | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 15:56, 5 December 2019
|
Ventricular tachycardia Microchapters |
|
Differentiating Ventricular Tachycardia from other Disorders |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Ventricular tachycardia screening On the Web |
|
Risk calculators and risk factors for Ventricular tachycardia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
According to the 2017 American Heart Association guidelines screening of first-degree relatives is recommended when a patient presents with any of the symptoms such as QT syndrome, hypertrophic or dilated cardiomyopathy and right ventricular dysplasia
Screening
According to the 2017 American Heart Association /American College of Cardiology/Heart Rhythm Society guideline screening of first-degree relatives is recommended when a patient is identified as having any of the following:[1][2]
- QT syndrome
- Hypertrophic or dilated cardiomyopathy
- Right ventricular dysplasia
References
- ↑ Shoubkhova TS (July 1968). "[Determination of the particle size of suspensions of dried bacteria by the method of turbidimetric analysis]". Zh. Mikrobiol. Epidemiol. Immunobiol. (in Russian). 45 (7): 108–10. PMID 5731530.
- ↑ Flannery MD, La Gerche A (January 2019). "Sudden Death and Ventricular Arrhythmias in Athletes: Screening, De-Training and the Role of Catheter Ablation". Heart Lung Circ. 28 (1): 155–163. doi:10.1016/j.hlc.2018.10.004. PMID 30554599.
Normal 0 false false false EN-US X-NONE X-NONE